Back to Search
KENNETH ROLSTON, M.D.
M.D.
Infectious Disease Physician
NPI: 1881785350Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
G4697(TX)
Research & Publications (20)
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.
PMID 19387695·Support Care Cancer·2010
8-other
New antimicrobial agents for the treatment of bacterial infections in cancer patients.
PMID 19569253·Hematol Oncol·2009
6-review
Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
PMID 19194365·Clin Adv Hematol Oncol·2008
6-review
Polymicrobial infection in patients with cancer: an underappreciated and underreported entity.
PMID 17578784·Clin Infect Dis·2007
6-review
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
PMID 16628654·Cancer·2006
8-other
The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
PMID 16439177·Int J Infect Dis·2006
8-other
Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
PMID 15768330·Clin Infect Dis·2005
8-other
Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones.
PMID 15766609·Diagn Microbiol Infect Dis·2005
8-other
The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
PMID 15250020·Clin Infect Dis·2004
8-other
In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients.
PMID 15523180·Chemotherapy·2004
4-observational
Oral antibiotic administration and early hospital discharge is a safe and effective alternative for treatment of low-risk neutropenic fever.
PMID 14585265·Cancer Treat Rev·2003
8-other
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients.
PMID 14522520·Diagn Microbiol Infect Dis·2003
4-observational
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
PMID 12458127·Diagn Microbiol Infect Dis·2002
4-observational
In vitro activity of ertapenem against bacterial isolates from cancer patients.
PMID 12106955·Diagn Microbiol Infect Dis·2002
8-other
Effect of fluconazole on agar invasion by Candida albicans.
PMID 11192509·J Med Microbiol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1881785350
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile